NDC 10544-464

Methocarbamol

Methocarbamol

Methocarbamol is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Blenheim Pharmacal, Inc.. The primary component is Methocarbamol.

Product ID10544-464_23cd352d-9463-4cbe-e054-00144ff88e88
NDC10544-464
Product TypeHuman Prescription Drug
Proprietary NameMethocarbamol
Generic NameMethocarbamol
Dosage FormTablet
Route of AdministrationORAL
Marketing Start Date2014-01-22
Marketing CategoryANDA / ANDA
Application NumberANDA086988
Labeler NameBlenheim Pharmacal, Inc.
Substance NameMETHOCARBAMOL
Active Ingredient Strength750 mg/1
Pharm ClassesCentrally-mediated Muscle Relaxation [PE],Muscle Relaxant [EPC]
NDC Exclude FlagE
Listing Certified Through2017-12-31

Packaging

NDC 10544-464-60

60 TABLET in 1 BOTTLE (10544-464-60)
Marketing Start Date2014-02-09
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 10544-464-60 [10544046460]

Methocarbamol TABLET
Marketing CategoryANDA
Application NumberANDA086988
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2014-02-09
Inactivation Date2020-01-31

NDC 10544-464-90 [10544046490]

Methocarbamol TABLET
Marketing CategoryANDA
Application NumberANDA086988
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2014-02-09
Inactivation Date2020-01-31

NDC 10544-464-00 [10544046400]

Methocarbamol TABLET
Marketing CategoryANDA
Application NumberANDA086988
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2014-02-24
Inactivation Date2020-01-31

NDC 10544-464-20 [10544046420]

Methocarbamol TABLET
Marketing CategoryANDA
Application NumberANDA086988
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2014-01-22
Inactivation Date2020-01-31

NDC 10544-464-02 [10544046402]

Methocarbamol TABLET
Marketing CategoryANDA
Application NumberANDA086988
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2014-02-24
Inactivation Date2020-01-31

NDC 10544-464-40 [10544046440]

Methocarbamol TABLET
Marketing CategoryANDA
Application NumberANDA086988
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2014-01-22
Inactivation Date2020-01-31

NDC 10544-464-84 [10544046484]

Methocarbamol TABLET
Marketing CategoryANDA
Application NumberANDA086988
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2014-01-22
Inactivation Date2020-01-31

NDC 10544-464-30 [10544046430]

Methocarbamol TABLET
Marketing CategoryANDA
Application NumberANDA086988
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2014-02-24
Inactivation Date2020-01-31

Drug Details

Active Ingredients

IngredientStrength
METHOCARBAMOL750 mg/1

OpenFDA Data

SPL SET ID:4cd1701a-c4f2-429a-a4db-185ece4e9a58
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 197943
  • 197944
  • Pharmacological Class

    • Centrally-mediated Muscle Relaxation [PE]
    • Muscle Relaxant [EPC]

    Medicade Reported Pricing

    10544046490 METHOCARBAMOL 750 MG TABLET

    Pricing Unit: EA | Drug Type:

    NDC Crossover Matching brand name "Methocarbamol" or generic name "Methocarbamol"

    NDCBrand NameGeneric Name
    0143-1290MethocarbamolMethocarbamol
    0143-1292MethocarbamolMethocarbamol
    0179-0092MethocarbamolMethocarbamol
    0276-0510MethocarbamolMethocarbamol
    0404-9909MethocarbamolMethocarbamol
    0440-1740Methocarbamolmethocarbamol
    0517-1825Methocarbamolmethocarbamol
    0603-4485Methocarbamolmethocarbamol
    0603-4486Methocarbamolmethocarbamol
    0615-7572Methocarbamolmethocarbamol
    0615-7573Methocarbamolmethocarbamol
    0615-8435METHOCARBAMOLMETHOCARBAMOL
    0615-8436METHOCARBAMOLMETHOCARBAMOL
    0904-7057MethocarbamolMethocarbamol
    0904-7058MethocarbamolMethocarbamol
    10135-664MethocarbamolMethocarbamol
    10135-665MethocarbamolMethocarbamol
    10544-259MethocarbamolMethocarbamol
    10544-464MethocarbamolMethocarbamol
    10544-622MethocarbamolMethocarbamol
    10544-773MethocarbamolMethocarbamol
    10544-956Methocarbamolmethocarbamol
    17511-505METHOCARBAMOLMETHOCARBAMOL
    17511-506METHOCARBAMOLMETHOCARBAMOL
    21695-078MethocarbamolMethocarbamol
    21695-079MethocarbamolMethocarbamol
    68071-1874MethocarbamolMethocarbamol
    68071-4365MethocarbamolMethocarbamol
    68071-4458MethocarbamolMethocarbamol
    68071-4505MethocarbamolMethocarbamol
    68083-317MethocarbamolMethocarbamol
    68084-056MethocarbamolMethocarbamol
    68071-4520MethocarbamolMethocarbamol
    68084-057MethocarbamolMethocarbamol
    68151-2775MethocarbamolMethocarbamol
    68387-340MethocarbamolMethocarbamol
    68387-342MethocarbamolMethocarbamol
    68475-002MethocarbamolMethocarbamol
    68788-6391MethocarbamolMethocarbamol
    68788-9076MethocarbamolMethocarbamol
    68788-9075MethocarbamolMethocarbamol
    68788-9388MethocarbamolMethocarbamol
    68788-9768MethocarbamolMethocarbamol
    68788-9376MethocarbamolMethocarbamol
    69543-134MethocarbamolMethocarbamol
    69543-135MethocarbamolMethocarbamol
    70010-754MethocarbamolMethocarbamol
    70069-101MethocarbamolMethocarbamol
    70010-770MethocarbamolMethocarbamol
    70518-0024MethocarbamolMethocarbamol

    © 2023 FDA.report
    This site is not affiliated with or endorsed by the FDA.